July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Late-Window Stroke: Hyperglycemia Doesn’t Alter EVT Benefit
Jul 5, 2025, 17:38

Late-Window Stroke: Hyperglycemia Doesn’t Alter EVT Benefit

The International Journal of Stroke recently shared a post on X:

”Just Accepted! Study in those with acute ischemic stroke and large vessel occlusion of the anterior circulation. Results show hyperglycaemia does not modify the efficacy of endovascular therapy in the late time window.”

Read the full article here.

Hyperglycemia has long been the unwelcome guest at the stroke table, often associated with worse outcomes and suspected of meddling with treatment effects—especially in early endovascular therapy (EVT).

Naturally, one might expect it to play a similarly disruptive role in patients treated in the late window (6 to 24 hours after symptom onset or last known well).

But in the study of anterior circulation large vessel occlusion stroke, Clemens Kersten et al. showed that hyperglycemia had surprisingly little to say.

Regardless of admission glucose levels, the benefit of EVT remained unchanged.

In conclusion, no evidence that admission glucose or hyperglycemia modifies the benefit of EVT in this population, suggesting EVT efficacy remains consistent across a range of glucose levels in the late window setting.

Stay updated on the advancements in science in the field of thrombosis with Hemostasis Today.